Long Table Growth Corp. 8-K

What Happened

• Long Table Growth Corp. announced on June 11, 2026 (reporting events that occurred June 5, 2026) that it consummated its initial public offering of 17,250,000 units at $10.00 per unit, generating gross proceeds of $172,500,000. The underwriters’ overallotment option was exercised in full (2,250,000 units).
• Each Unit consists of one Class A ordinary share and one-half of a redeemable warrant (one whole Warrant entitles the holder to purchase one Class A share at $11.50 per share, subject to adjustment). Simultaneously, the company completed a private placement of 3,600,000 warrants to Long Table Growth Sponsor LLC at $1.00 per warrant, generating $3,600,000.
• Approximately $173,363,000 of the proceeds (about $10.05 per Unit), which includes up to $5,175,000 of the underwriter’s deferred commission, was deposited into a U.S.-based trust account held by Continental Stock Transfer & Trust Company. An audited balance sheet as of June 5, 2026 reflecting receipt of these proceeds is included as Exhibit 99.1 to the filing.

Key Details

• IPO units sold: 17,250,000 units at $10.00 each — gross proceeds $172,500,000.
• Underwriters’ overallotment exercised in full: 2,250,000 additional units.
• Private placement: 3,600,000 warrants sold to Sponsor at $1.00 each — $3,600,000.
• Amount placed in trust: approx. $173,363,000 (≈ $10.05 per Unit), including up to $5,175,000 underwriter deferred commission; trustee: Continental Stock Transfer & Trust Company.
• Exhibit included: Audited balance sheet as of June 5, 2026 (Exhibit 99.1).

Why It Matters

• The filing documents the company’s capital raise and the securities issued (shares and warrants), providing investors with concrete figures on cash raised and outstanding warrant obligations.
• Funds being held in a trust account are a material detail for investors because they show where proceeds are placed pending the company’s next steps; the audited balance sheet confirms receipt of those proceeds.
• The private placement warrants to the Sponsor and the public warrants (exercise price $11.50) are important to consider for future dilution and potential share issuance, as they represent additional claims on equity if exercised.